Clinical Trial Update: Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravitreal ranibizumab with triamcinolone acetonide (TA) combination therapy versus ranibizumab alone for polypoidal choroidal vasculo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy
• Wet Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)
• Triamcinolone Acetonide (TA) (triamcinolone acetonide)

Snippet

Sponsor: Aier School of Ophthalmology, Central South University | Conditions: Wet Macular Degeneration | Phase 4 | Status: UNKNOWN